clopidogrel has been researched along with Atrial Septal Defect in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Cheema, AN; Côté, M; Horlick, E; Houde, C; Ibrahim, R; Labinaz, M; Marrero, A; Marsal, JR; Nadeem, N; Osten, M; Rivest, D; Rodés-Cabau, J; Wintzer-Wehekind, J | 1 |
| Kang, HJ; Kim, HS; Kim, SH; Koo, BK; Lee, HY; Park, KW; Seo, JB | 1 |
| Cheema, AN; Côté, M; Horlick, E; Houde, C; Ibrahim, R; Labinaz, M; Marrero, A; Marsal, JR; Nadeem, N; Osten, M; Rivest, D; Rodés-Cabau, J | 1 |
| Arı, H; Arı, S; Bozat, T; Koca, V | 1 |
| Böhm, M; Fries, R | 1 |
| Barry, WH; Coletti, AT; Jessup, DB; Muhlestein, JB; Shean, FC; Whisenant, BK | 1 |
| Elkind, MS | 1 |
| Burks, J; Sharifi, M | 1 |
| Al-Bustami, O; Burks, J; Dehghani, M; Emrani, F; Mehdipour, M; Sharifi, M | 1 |
| Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT | 1 |
| Brandt, R; Burian, M; Geisslinger, G; Hamm, C; Mitrovic, V; Neumann, T; Weber, M | 1 |
2 review(s) available for clopidogrel and Atrial Septal Defect
| Article | Year |
|---|---|
[Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure].
Topics: Abciximab; Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Antibodies, Monoclonal; Anticholesteremic Agents; Arrhythmias, Cardiac; Aspirin; Atorvastatin; Clopidogrel; Defibrillators, Implantable; Double-Blind Method; Fibrinolytic Agents; Heart Failure; Heart Septal Defects, Atrial; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Regeneration; Risk Factors; Syndrome; Ticlopidine; Time Factors; Tirofiban; Tyrosine | 2003 |
The role of warfarin and aspirin in secondary prevention of stroke.
Topics: Anticoagulants; Aspirin; Clopidogrel; Heart Septal Defects, Atrial; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2004 |
2 trial(s) available for clopidogrel and Atrial Septal Defect
| Article | Year |
|---|---|
Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: One-Year Results of the CANOA Randomized Clinical Trial.
Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Dual Anti-Platelet Therapy; Duration of Therapy; Female; Heart Septal Defects, Atrial; Humans; Male; Middle Aged; Migraine Disorders; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications | 2021 |
Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial.
Topics: Aspirin; Cardiac Catheterization; Cardiac Surgical Procedures; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Headache Disorders, Secondary; Heart Septal Defects, Atrial; Humans; Male; Middle Aged; Migraine Disorders; Platelet Aggregation Inhibitors; Regression Analysis; Ticlopidine; Treatment Outcome | 2015 |
7 other study(ies) available for clopidogrel and Atrial Septal Defect
| Article | Year |
|---|---|
Comparison of Angiographic Outcomes of Side Branch Ostium at Bifurcation Coronary Lesion between Two-stent and One-stent Techniques.
Topics: Aspirin; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Female; Heart; Heart Septal Defects, Atrial; Humans; Male; Middle Aged; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome | 2015 |
[Simultaneous transcatheter treatment of perimembranous ventricular septal defect and secundum atrial septal defect in an adult: first application in Turkey].
Topics: Anesthetics, Intravenous; Clopidogrel; Echocardiography, Transesophageal; Female; Fluoroscopy; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Humans; Midazolam; Platelet Aggregation Inhibitors; Septal Occluder Device; Ticlopidine; Turkey; Young Adult | 2011 |
Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Cerebrovascular Disorders; Clopidogrel; Coronary Angiography; Coronary Disease; Equipment Design; Feasibility Studies; Female; Follow-Up Studies; Heart Failure; Heart Septal Defects, Atrial; Heart Valve Diseases; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Treatment Outcome; Venous Thrombosis; Warfarin | 2003 |
Efficacy of clopidogrel in the treatment of post-ASD closure migraines.
Topics: Balloon Occlusion; Clopidogrel; Epilepsy; Heart Septal Defects, Atrial; Humans; Migraine Disorders; Platelet Aggregation Inhibitors; Ticlopidine | 2004 |
Intense migraines secondary to percutaneous closure of atrial septal defects.
Topics: Adult; Cardiac Catheterization; Clopidogrel; Echocardiography, Transesophageal; Female; Follow-Up Studies; Heart Septal Defects, Atrial; Humans; Male; Migraine without Aura; Minimally Invasive Surgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome | 2005 |
Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects.
Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Female; Heart Septal Defects, Atrial; Humans; Male; Medical Audit; Middle Aged; Migraine with Aura; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Ticlopidine | 2005 |
Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder.
Topics: Adult; Aged; Alloys; Aspirin; Clopidogrel; Female; Heart Septal Defects, Atrial; Humans; Male; Middle Aged; Nickel; Platelet Aggregation Inhibitors; Prostheses and Implants; Ticlopidine | 2006 |